Guardion Health Sciences Inc

Guardion Health Sciences — Investor Presentation (September 2021)

17 slides from Guardion Health Sciences's investor presentation, Sep 10, 2021

  1. Slide 1: Shape the future with momentum

    Shape the future with momentum Guardion is a company infused with motion and driven by innovation, working to improve quality of life through our clinical nutrition products. GUARDION HEALTH SCIENCES September, 2021

  2. Slide 2: Forward Looking Statement

    / Forward Looking Statement ” “we,” “us, This presentation of Guardion Health Sciences, Inc. (the “company,” “Guardion, or “our”) includes "forward-looking statements" intended to _ qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These

  3. Slide 3: Corporate Overview

    | /Corporate Overview _” Guardion Health Sciences (Nasdaq: GHSI), is a Trading Symbol Nasdaq: GHSI clinical nutrition and diagnostics company that Market Capitalization ~$31M offers a portfolio of science-based, clinically- supported nutritional supplements, medical Recent Share Price $1.28 foods, a

  4. Slide 4: Synergy between Viactiv and legacy Organization will Accelerate Growth

    J /Synergy between Viactiv and legacy Organization / will Accelerate Growth Guardion Guardion of 2021 (and beyond) (pre-Viactiv) Clinical investment Strong brand Scientific advisors Consumer-loved products Doctor education Marketing expertise Extensive Distribution Channels G e N HEALTH SCIENCES 4

  5. Slide 5: Highlights

    Highlights Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, ocular, and immune health Well defined value creation process focused on clinical evidence, product development and targeted marketing Science

  6. Slide 6: Nutrition Industry is Large and Growing

    "Nutrition Industry is Large and Growing / Global Supplement and Medical 7 Food Market ; : “* Increasing awareness of the importance of nutrition 326 Bn . . . ** Growing body of research demonstrating benefits of nutrition ** Increasing geriatric population with unique nutritional needs $153 Bn op A

  7. Slide 7: Well Defined Value Creation Process

    ] i, Well Defined Value Creation Process Customer SEIS Clinical Strong Product Targeted Needs pase Evidence Claims Development Marketin Formulation P 9 Understand the Create Execute clinical Identify product Create products Execute cost needs of science-based work on the claims based with a format e

  8. Slide 8: Leveraging Clinical Evidence

    ‘Leveraging Clinical Evidence Guardion is leveraging and creating a science / evidence-based foundation through clinical studies to support our nutrition product portfolio Investing in clinical research is fundamental to our model New placebo-controlled clinical study initiated on Glaucocetin in a n

  9. Slide 9: Viactiv is a Strong Growing Brand

    7 Niactiv® is a Strong Growing Brand with Potential for Expansion GUARDION HEALTH SCIENCES

  10. Slide 10: Consumer Experience and Distribution

    , ys Consumer Experience and Distribution Viactiv is a top brand in the calcium dietary supplement segment “ One of the fastest growing Calcium supplement brand, +8.6% YOY Nic “* Increasing market share ($) to 5.7% (+0.7pt YOY) “ Strong distribution in nearly every top retail chain © TARGET Niactiv

  11. Slide 11: Organic Growth via Product Development & Commercialization

    “» Same base Calcium, plus high potency Vitamin D to boost immune system and calcium absorption “* Zinc to support the ex oe & *» New Orange Cream * Clinically proven to increase protective macular pigment Clinically proven to improve contrast sensitivity 3x better carotenoid bioavailability vs. lea

  12. Slide 12: Management and Board of Directors

    Bret Scholtes David W. Evans, PhD. Craig J. Sheehan Jeff Benjamin Susan Klein, ND Chief Executive Officer Chief Science Officer Chief Commercial Officer Chief Accounting Officer Director of Board of Directors Board of Directors Medical Education N Robert N. Weingarten Mark Goldstone Kelly J. Anderso

  13. Slide 13: Financial Highlights

    7 Financial Highlights ** Closed the Viactiv acquisition on June 1, 2021 “» For 2Q21, total revenue was $1.2 M; Viactiv contributed for one month during the quarter and represented ~86% of GHSI total sales “» Cash and short-term investments at 6/30/21 was $12.5M and working capital was $14.7M; No de

  14. Slide 14: Strategic Priorities — Driving Growth and Creating Value

    ’ Strategic Priorities — Driving Growth and Creating Value Brand Strategy — developing a strategy that best leverages Viactiv’s strong consumer awareness and acceptance Product Strategy — focusing product portfolio on differentiated formulations, product taste, compelling product formats, and compet

  15. Slide 15: Potential Actions Over the Next Few Quarters

    Potential Actions Over the Next Few Quarters « Improve communications channels *« Complete and implement the results of business unit and product evaluation « New product development and product launches * Cost reduction activities and optimizing internal processes « Ramp up of commercial activities

  16. Slide 16: Highlights

    Highlights Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, ocular, and immune health Well defined value creation process focused on clinical evidence, product development and targeted marketing Science

  17. Slide 17: Guardion Health Sciences is a clinical nutrition and diagnostics company

    Guardion Health Sciences is a clinical nutrition and diagnostics GUARDION company that offers a portfolio of science-based, clinically- supported nutritional supplements, medical foods, and HEALTH SCIENCES diagnostic products that support healthcare professionals, their patients, and consumers in ac

Guardion Health Sciences — Investor Presentation (September 2021) on 6ix